Kazuo Noguchi

Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1–positive advanced non–small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies

Kaname Nosaki, Hideo Saka, Yukio Hosomi et al. · Lung Cancer · 2019 · 274 citations

Elderly Patients, Medicine, Pembrolizumab Monotherapy +9

Requirement of H‐2 heterozygosity for autoimmunity in (NZB × NZW)F₁ hybrid mice

Short Paper, Sachiko Hirose, Genjiro Ueda et al. · European Journal of Immunology · 1986 · 99 citations

Phase 1b study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced melanoma (KEYNOTE-041)

Naoya Yamazaki, Tatsuya Takenouchi, Manabu Fujimoto et al. · Cancer Chemotherapy and Pharmacology · 2017 · 86 citations · Full text

Phase 1B, Anti-pd-1 Monoclonal Antibody, Medicine +7

The effect of electrical muscle stimulation on the prevention of disuse muscle atrophy in patients with consciousness disturbance in the intensive care unit

Tomoya Hirose, Tadahiko Shiozaki, Kentaro Shimizu et al. · Journal of Critical Care · 2013 · 75 citations

Stimulation Device, Electrophysiological Evaluation, Intensive Care Unit +12

Functional Modulation of Human Recombinant γ-Aminobutyric Acid Type A Receptor by Docosahexaenoic Acid

Junichi Nabekura, Kazuo Noguchi, Michael‐Robin Witt et al. · Journal of Biological Chemistry · 1998 · 68 citations · Full text